摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-1-((S)-2-((benzyloxy)carbonyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-aminium chloride | 87297-14-1

中文名称
——
中文别名
——
英文名称
(S)-1-((S)-2-((benzyloxy)carbonyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-aminium chloride
英文别名
L-phenylalanyl-L-proline benzyl ester hydrochloride;H-Phe-Pro-OBzl*HCl;HCl*Phe-Pro-OBzl;HCl*HPheProOBzl;H-Phe-Pro-OBzl hydrochloride;L-phenylalanyl-L-proline, benzyl ester, hydrochloride;L-phenylalanyl-L-proline benzylester hydrochloride;benzyl (2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carboxylate;hydrochloride
(S)-1-((S)-2-((benzyloxy)carbonyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-aminium chloride化学式
CAS
87297-14-1;96935-61-4
化学式
C21H24N2O3*ClH
mdl
——
分子量
388.894
InChiKey
VWVBMRYJHXTMMX-HLRBRJAUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.71
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    72.6
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Non-linear hydrophobic-induced pKa shifts: Implications for efficiency of conversion to chemical energy
    作者:Dan W. Urry、D. Channe Gowda、Shao Qing Peng、Timothy M. Parker
    DOI:10.1016/0009-2614(95)00442-7
    日期:1995.6
    Phe residues, a non-linear hydrophobic-induced pKa shift was observed with a ΔpKa of 0.4 (Asp) and 0.3 (Glu) on addition to 2 Phe residues per 30mer but with a ΔpKa of 4.7 (Asp) and 2.7 (Glu) on going from 4 Phe/30mer to 5 Phe/30mer. As a shift in pKa can be equivalent to the conversion to chemical energy from whatever energy input — mechanical, chemical, electrochemical, pressure or light — which effects
    通过在能够显示疏水折叠和组装过渡的聚三糖肽中每三十个残基使用一个Asp或一个Glu,并将五个Val残基中的一组(最接近Asp或Glu残基)逐步转变为疏水性更高的Phe残基,非线性疏水诱导的p ķ一个移位用观察到Δ p ķ一个上除了每30聚体,但用2个的Phe残基的0.4(ASP)和0.3(谷氨酸)Δ p ķ一个4.7(ASP)和2.7 (Glu)从4 Phe / 30mer升至5 Phe / 30mer。作为p K a的偏移可以等同于从任何能量输入(机械,化学,电化学,压力或光能)转化为化学能,这会影响疏水性的变化,非线性疏水诱导的p K a位移意味着能量转化的效率随着蛋白质基聚合物的疏水性。
  • Hydrophobicity dependence of oxidation of tetrapeptides of elastin sequences with Mn(III): Synthesis, characterization, kinetics, and mechanistic study
    作者:B. K. Kempe Gowda、H. S. Prasad、K. S. Rangappa、D. Channe Gowda
    DOI:10.1002/kin.10015
    日期:2002.1
    The analogues of elastin sequences, glycyl-glycyl-alanyl-proline (GGAP), glycyl-glycyl-phenylalanyl-proline (GGFP), and glycyl-glycyl-isoleucyl-proline (GGIP) were synthesized by classical solution phase method and characterized. The kinetics of oxidation of these tetrapeptides (TETP) by Mn(III) has been studied in the presence of sulphate ions in acidic solution at 25°C. The reaction was followed
    弹性蛋白序列的类似物,甘氨酰-甘氨酰-丙氨酰-脯氨酸(GGAP)、甘氨酰-甘氨酰-苯丙氨酰-脯氨酸(GGFP)和甘氨酰-甘氨酰-异亮氨酰-脯氨酸(GGIP)通过经典液相法合成并表征。在 25°C 酸性溶液中存在硫酸根离子的情况下,研究了 Mn(III) 对这些四肽 (TETP) 的氧化动力学。在 λmax = 500 nm 处用分光光度法跟踪反应。观察到速率对 [Mn(III)] 和 [TETP] 的一级依赖性。该速率与还原产物、Mn(II) 和氢离子的浓度无关。研究了改变介质介电常数和添加阴离子(如硫酸盐、氯化物或高氯酸盐)的影响。激活参数已使用 Arrhenius 和 Erying 图进行了评估。氧化产物被分离和表征。提出了在限速步骤中涉及 TETP 与 Mn(III) 反应的机制。在这些序列的氧化速率和疏水性之间注意到明显的相关性,其中增加的疏水性导致增加的氧化速率。© 2001 John
  • Dipeptide derivatives and antihypertensive drugs containing them
    申请人:Ajinomoto Co., Inc.
    公开号:US04971993A1
    公开(公告)日:1990-11-20
    There are disclosed dipeptide derivatives represented by the general formula: ##STR1## wherein R.sup.1 is a radical selected from the group consisting of alkyl, aralkyl and aryl groups optionally containing one or more substituent groups, R.sup.2 is a radical selected from the group consisting of hydrogen atoms and alkyl, aralkyl and aryl groups optionally containing one or more substituent groups, R.sup.3 is a radical selected from the group consisting of hydrogen atoms and alkyl, aralkyl and aryl groups optionally containing one or more substituent groups, R.sup.4 is a radical selected from the group consisting of hydrogen atoms and alkyl, aralkyl and aryl groups optionally containing one or more substituent groups, and R.sup.5 is a radical selected from the group consisting of hydroxyl, amino, hydroxyamino, alkyloxy, aralkyloxy, aryloxy, alkylamino, aralkylamino, arylamino, alkyloxyamino, aralkyloxyamino, aryloxyamino, acylamino and sulfonylamino groups, which alkyloxy, aralkyloxy and aryloxy groups optionally containing one or more substituent groups; wherein R.sup.3 may be combined with R.sup.2 or R.sup.4 to form an alkylene bridge optionally containing one or more oxygen atoms, sulfur atoms and nitrogen atoms and optionally containing one or more substituent groups. However, certain dipeptide derivatives within the above general formula are excluded from the invention. The dipeptide derivatives are useful for the treatment of hypertension.
    本发明公开了一种二肽衍生物,其通式为:##STR1## 其中,R.sup.1是从烷基,芳基烷基和芳基组成的基团中选择的基团,可选地含有一个或多个取代基团;R.sup.2是从氢原子和烷基,芳基烷基和芳基组成的基团中选择的基团,可选地含有一个或多个取代基团;R.sup.3是从氢原子和烷基,芳基烷基和芳基组成的基团中选择的基团,可选地含有一个或多个取代基团;R.sup.4是从氢原子和烷基,芳基烷基和芳基组成的基团中选择的基团,可选地含有一个或多个取代基团;R.sup.5是从羟基,氨基,羟氨基,烷氧基,芳基烷氧基,芳氧基,烷基氨基,芳基烷基氨基,芳基氨基,烷氧基氨基,芳基烷氧基氨基,芳氧基氨基,酰基氨基和磺酰基氨基组成的基团中选择的基团,其中,烷氧基,芳基烷氧基和芳氧基基团可选地含有一个或多个取代基团;其中,R.sup.3可以与R.sup.2或R.sup.4结合形成一个烷基桥,可选地含有一个或多个氧原子,硫原子和氮原子,并可选地含有一个或多个取代基团。然而,上述通式中的某些二肽衍生物被排除在本发明之外。这些二肽衍生物对高血压的治疗有用。
  • Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials – A novel approach to enhance biocompatibility
    作者:R. Suhas、S. Chandrashekar、D. Channe Gowda
    DOI:10.1016/j.ejmech.2010.12.005
    日期:2011.2
    The peptides of elastin sequences chosen for the present study included tetrapeptides, pentapeptides and tricosapeptides (30 amino acids), synthesized by classical solution phase method and conjugated to [3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole]. The structures of the compounds were confirmed by physical and spectroscopic techniques followed by the antimicrobial evaluation by both agar well diffusion and microdilution methods. Here we wish to report the effect of conjugation of these moieties which enabled us to identify a novel set of peptides conjugated to heterocycle which have exhibited more potent antimicrobial activity than the conventional drugs used. Further, conjugates of tricosamers 34 and 35 were able to inhibit the growth of fungal species at 3-5 mu g/mL which is nearly 5 fold more potent than the reference drug. (C) 2010 Elsevier Masson SAS. All rights reserved.
  • Structure-Based Rationale Design and Synthesis of Aurantiamide Acetate Analogues - Towards a New Class of Potent Analgesic and Anti-inflammatory Agents
    作者:Ramesh Suhas、Dase Channe Gowda
    DOI:10.1111/j.1747-0285.2012.01331.x
    日期:2012.5
    A series of new aurantiamide acetate analogues were synthesized by modifying its N‐terminal substitution and the amino acid residue. The structure of all these compounds was established on the basis of analytical and spectral studies. All the new derivatives were evaluated in vivo for their analgesic activity by tail flick method in mice and anti‐inflammatory activity against carrageenan‐induced oedema in albino rats at different doses (25, 50 and 100 mg/kg body weight). All the compounds exhibited significant pharmacological activity with no ulcerogenic liability. In particular, pentapeptides and tricosamers (30 amino acids) containing analogues have demonstrated high potency than the reference standards. These compounds hold promise for further development.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物